Page last updated: 2024-10-22

amlexanox and Osteoarthritis, Knee

amlexanox has been researched along with Osteoarthritis, Knee in 1 studies

amlexanox: SRA-A antagonist;structure given in first source
amlexanox : A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.

Osteoarthritis, Knee: Noninflammatory degenerative disease of the knee joint consisting of three large categories: conditions that block normal synchronous movement, conditions that produce abnormal pathways of motion, and conditions that cause stress concentration resulting in changes to articular cartilage. (Crenshaw, Campbell's Operative Orthopaedics, 8th ed, p2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sueishi, T1
Akasaki, Y1
Goto, N1
Kurakazu, I1
Toya, M1
Kuwahara, M1
Uchida, T1
Hayashida, M1
Tsushima, H1
Bekki, H1
Lotz, MK1
Nakashima, Y1

Other Studies

1 other study available for amlexanox and Osteoarthritis, Knee

ArticleYear
GRK5 Inhibition Attenuates Cartilage Degradation via Decreased NF-κB Signaling.
    Arthritis & rheumatology (Hoboken, N.J.), 2020, Volume: 72, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminopyridines; Animals; Cartilage, Articular; Chondrocy

2020